PULSE BIOSCIENCES, INC.(PLSE)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

PULSE BIOSCIENCES, INC. (PLSE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PLSE at 14.4/100 on a 32-signal composite quality model, placing it at rank #2,864 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), PULSE BIOSCIENCES, INC. reports quarterly revenue of $434.0K, net income of $-24.7M, free cash flow of $-18.8M. Top institutional holders of PLSE by reported 13-F value include BlackRock, BANK OF AMERICA, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. PLSE trades on the Nasdaq exchange and files with the SEC under CIK 1625101. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PLSE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PULSE BIOSCIENCES, INC. directly from SEC EDGAR.